Approval · Notice of Compliance 676 · 2002
CONRAY 30: Notice of Compliance 676
Issued July 2, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 676
- Date
- July 2, 2002
- Company
- Tyco HealthcarePointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Ionic, water soluble radiopaque contrast medium for intravascular use
Products in this notice
Medicinal ingredients
- IOTHALAMATE MEGLUMINE 300 MG per ML
- IOTHALAMATE MEGLUMINE 430 MG per ML
- IOTHALAMATE MEGLUMINE 600 MG per ML